Skip to main content
. 2019 Jul 8;25(2):217–239. doi: 10.1007/s10147-019-01498-8

Fig. 6.

Fig. 6

Recommendations by cancer type. *Since biomarkers, such as expression of PD-L1, have different priorities, you should note to perform biomarker testing and dMMR testing at the same time or sequentially